Mold prompts recall of 5,000 vials of J&J's Risperdal Consta

Johnson & Johnson recalled an estimated 5,000 of the 70,000 vials of antipsychotic drug Risperdal Consta manufactured in one lot last year after testing positive for Alternaria alternata mold during routine quality inspection. The products must be pulled because they remain unused in pharmacies, community mental health centers and doctor's offices.

View Full Article in:

Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Catheter Engineer Manager
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD